All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

502

Reset

502 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • TTAX01Phase 31 trial

    BioTissue Holdings, Inc · Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer

  • VX-017Phase 31 trial

    Vertex Pharmaceuticals · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • StromaForteHuman Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product, MSCsPhase 25 trials

    Cellcolabs Clinical LTD. · Cardiovascular Diseases, Frailty, Musculoskeletal Injury

  • AtibuclimabIC14Phase 24 trials

    Implicit Bioscience · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury

  • NeflamapimodVX-745Phase 24 trials

    EIP Pharma Inc · Nonfluent Variant Primary Progressive Aphasia (nfvPPA), Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke

  • RimonabantPhase 24 trials

    Sinfatin S.L · Chronic Stroke, Subacute Stroke, Post-COVID-19 Syndrome

  • SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials

    PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke

  • Umbilical Cord Mesenchymal Stem CellsMesenchymal stromal cells, Allogeneic Mesenchymal Stem CellsPhase 24 trials

    PT. Prodia Stem Cell Indonesia · Diabetic Nephropathy Type 2, Ischemic Stroke, Cerebral Palsy

  • Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction

  • AZD9550Phase 23 trials

    AstraZeneca · Overweight and Obesity, Obesity/Overweight, Obesity or Overweight

  • BudoprutugTNT119Phase 23 trials

    Climb Bio, Inc. · Primary Membranous Nephropathy, Systemic Lupus Erthematosus, Immune Thrombocytopenia (ITP)

  • CID-103Phase 23 trials

    CASI pharmaceuticals, Inc. · Chronic Immune Thrombocytopenia, Antibody Mediated Rejection

  • Dihuang Baoyuan Granulesprescription BPhase 23 trials

    Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Diabetes Mellitus, Type 2, Diabetes, Type2diabetes

  • ESG206ESG206-2Phase 23 trials

    Shanghai Escugen Biotechnology Co., Ltd · Systemic Lupus Erythematosus (SLE), Immune Thrombocytopenia (ITP), Primary Sjögren Syndrome

  • Fuling Yunhua Granulesprescription APhase 23 trials

    Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Diabetes Mellitus, Type 2, Diabetes, Type2diabetes

  • HRS-4729Phase 23 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Metabolic Dysfunction-Associated Steatohepatitis (MASH), Type 2 Diabetes, Overweight or Obesity

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • LT3001Phase 23 trials

    Lumosa Therapeutics Co., Ltd. · Acute Ischemic Stroke

  • LY4065967Phase 23 trials

    Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee

  • MacupatideLY3532226Phase 23 trials

    Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2

  • MAR001Phase 23 trials

    Marea Therapeutics · Hypertriglyceridemia

  • mesenchymal stem cellumbilical cord derived MSCsPhase 23 trials

    Cell Energy Life Sciences Group Co. LTD · AIDS, Ischemic Heart Disease, Osteoarthritis

  • NNC0519-0130Phase 23 trials

    Novo Nordisk · Chronic Kidney Disease, Diabetes Mellitus, Type 2, Obesity

  • NNC0662-0419Phase 23 trials

    Novo Nordisk · Obesity, Diabetes Mellitus, Type 2, Overweight

  • PetrelintideZP8396Phase 23 trials

    Zealand Pharma · Obesity, Autism Spectrum Disorder (ASD, Overweight

  • QCZ484Phase 23 trials

    Novartis · Hypertension (HTN), Hypertension, Hypercholesterolaemia

  • QLS-111Phase 23 trials

    Qlaris Bio, Inc. · Normal Tension Glaucoma (NTG), Glaucoma, Open-angle Glaucoma (OAG)

  • SAL0140Phase 23 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Primary Aldosteronism, Chronic Kidney Disease, Uncontrolled Hypertension

  • SPI-62clofutriben, ASP3662Phase 23 trials

    Sparrow Pharmaceuticals · Cortisol Excess, Type 2 Diabetes, Polymyalgia Rheumatica

  • ABBV-295Phase 22 trials

    AbbVie · Obesity, Overweight, Moderate to Severe Psoriasis

  • ABP-745Phase 22 trials

    Atom Therapeutics Co., Ltd · Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management

  • AC01Phase 22 trials

    AnaCardio AB · Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Reduced Ejection Fraction

  • GSK · Cardiovascular Disease, Respiratory Syncytial Virus Infections

  • ALN-4324Phase 22 trials

    Alnylam Pharmaceuticals · Type 2 Diabetes Mellitus (T2DM), Obese or Overweight Healthy Volunteers

  • ALT001Phase 22 trials

    Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. · Ischemic Stroke in the Sequelae Stage, Amyotrophic Lateral Sclerosis (ALS)

  • ARO-INHBEPhase 22 trials

    Arrowhead Pharmaceuticals · Metabolic Dysfunction-Associated Steatohepatitis, Obesity

  • AZD5004Phase 22 trials

    AstraZeneca · Obesity or Overweight, Diabetes Mellitus, Type 2

  • BGE-102Phase 22 trials

    BioAge Labs, Inc. · Diabetic Macular Edema (DME), Obesity and Cardiovascular Risk

  • BimagrumabLY3985863, BYM338Phase 22 trials

    Eli Lilly · Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction

  • BivamelagonLB54640Phase 22 trials

    Rhythm Pharmaceuticals, Inc. · Hypothalamic Obesity

  • BMF-219Phase 22 trials

    Biomea Fusion Inc. · Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus

  • CDR132LPhase 22 trials

    Novo Nordisk · Heart Failure

  • CIN-102 DosePhase 22 trials

    CinDome Pharma, Inc. · Idiopathic Gastroparesis, Diabetic Gastroparesis

  • CRD-4730Phase 22 trials

    Cardurion Pharmaceuticals, Inc. · Catecholaminergic Polymorphic Ventricular Tachycardia, Heart Failure With Reduced Ejection Fraction (HFrEF)

  • DFV890Phase 22 trials

    Novartis · Coronary Heart Disease, Symptomatic Knee Osteoarthritis

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • ECC4703Phase 22 trials

    Eccogene · Adult Obesity, Weight Management, Metabolic Dysfunction-associated Steatohepatitis

  • EDP167Phase 22 trials

    Eddingpharm (Zhuhai) Co., Ltd. · Mixed Dyslipidemia, Homozygous Familial Hypercholesterolemia (HoFH)

  • EnicepatideCT-388, RO7795068Phase 22 trials

    Carmot Therapeutics, Inc. · Obesity, Overweight, Overweight or Obese

NewerPage 6 of 11Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.